Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Why Elutia Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Published 19/09/2023, 12:59
© Reuters.  Why Elutia Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Benzinga - by Lisa Levin, Benzinga Editor.

Gainers

  • Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 73.5% to $0.1313 in pre-market trading after falling 15% on Monday.
  • Elutia Inc. (NASDAQ: ELUT) shares rose 54.8% to $1.92 in pre-market trading after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics LLC.
  • Galera Therapeutics, Inc. (NASDAQ: GRTX) shares rose 21.1% to $0.2309 in pre-market trading. Galera scheduled a Type A meeting with the FDA to discuss next steps for its radiotherapy avasopasem.
  • Senti Biosciences, Inc. (NASDAQ: SNTI) shares gained 20.8% to $0.5860 in pre-market trading after dipping around 17% on Monday.
  • Neptune Wellness Solutions Inc. (NASDAQ: NEPT) rose 17.5% to $5.43 in pre-market trading after falling 18% on Monday. Neptune Wellness announced intention to spinout Sprout Organics pursuant to the Morgan Stanley agreed to transaction.
  • Aclarion, Inc. (NASDAQ: ACON) shares jumped 13.6% to $0.4999 in pre-market trading after falling 12% on Monday.
  • Cybin Inc. (NYSE: CYBN) shares surged 12.8% to $0.5190 in pre-market trading. Cybin shares jumped over 39% on Monday after hedge fund owner Steve Cohen invested $19 million in the company.
  • Avinger, Inc. (NASDAQ: AVGR) shares climbed 11.6% to $6.78 in pre-market trading. Avinger shares jumped 47% on Monday amid the company announcing the commercial launch of its Tigereye ST image-guided CTO crossing device.
  • SelectQuote, Inc. (NYSE: SLQT) rose 10.6% to $1.25 in pre-market trading. Selectquote COO William Grant, III reported purchase of 150,000 shares at an average price of $1.20 per share in Form 4 filing on Monday.
  • Bit Brother Limited (NASDAQ: BETS) gained 9.7% to $0.68 in pre-market trading.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Digital Transformation Opportunities Corp. (NASDAQ: DTOC) fell 20.8% to $22.97 in pre-market trading after jumping 173% on Monday.
  • Rocket Lab USA, Inc. (NASDAQ: RKLB) shares fell 18.8% to $4.09 in pre-market trading as the company's 41st mission succumbs to technical issues, prompting it to postpone its next mission and revise its third-quarter guidance.
  • Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares fell 15.7% to $0.2866 in pre-market trading after declining 15% on Monday.
  • 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares fell 15.1% to $0.98 in pre-market trading after the company said it has withdrawn its COVID Phase IIB investigational new drug and announced plans to resubmit pending assessment of ability to meet FDA requirements.
  • Terran Orbital Corporation (NYSE: LLAP) fell 14.8% to $1.21 in pre-market trading after the company priced its previously announced public offering of 23.2 million shares and warrants to purchase up to 23.2 million shares at a combined public offering price of $1.40 per share and accompanying warrant.
  • Perspective Therapeutics, Inc. (NASDAQ: CATX) fell 13.8% to $0.2754 in pre-market trading after jumping 56% on Monday.
  • MSP Recovery, Inc. (NASDAQ: LIFW) fell 12.5% to $0.1069 in pre-market trading after dipping 35% on Monday.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) fell 11.1% to $0.4080 in pre-market. T2 Biosystems shares gained over 65% on Monday after the FDA cleared the company's biothreat panel for commercial distribution.
  • SCWorx Corp. (NASDAQ: WORX) fell 10.5% to $0.2337 in pre-market trading after jumping 38% on Monday.
  • FLJ Group Limited (NASDAQ: FLJ) fell 10.1% to $0.2723 in pre-market trading after declining 6% on Monday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.